Only 3 NPM1-mutated-AML were classified as favorable according to the molecular classifier and as intermediate or adverse according to the ELN classification because of high FLT3–ITD ratio (n = 2) or complex karyotype (n = 1). The gene discussed is NPM1; the disease is acute myeloid leukemia.